Methylenedioxymethoxyethylamphetamine
title: "Methylenedioxymethoxyethylamphetamine" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["methylenedioxyphenethylamines", "pihkal", "substituted-amphetamines"] topic_path: "general/methylenedioxyphenethylamines" source: "https://en.wikipedia.org/wiki/Methylenedioxymethoxyethylamphetamine" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
::data[format=table title="Infobox drug"]
| Field | Value |
|---|---|
| Verifiedfields | changed |
| Watchedfields | changed |
| verifiedrevid | 424728565 |
| drug_name | MDMEOET |
| image | MDMEOET.svg |
| image_class | skin-invert-image |
| width | 250px |
| routes_of_administration | Oral |
| ATC_prefix | None |
| duration_of_action | Unknown |
| CAS_number_Ref | |
| CAS_number | 74698-44-5 |
| PubChem | 44719584 |
| ChemSpiderID_Ref | |
| ChemSpiderID | 21106334 |
| UNII | YPA4B5U3U8 |
| synonyms | 3,4-Methylenedioxy-N-methoxyethylamphetamine; MDMEOET; MDMEOETA |
| IUPAC_name | 1-(2H-1,3-benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine |
| C | 13 |
| SMILES | CC(Cc1ccc2c(c1)OCO2)NCCOC |
| StdInChI_Ref | |
| StdInChI | 1S/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 |
| StdInChIKey_Ref | |
| StdInChIKey | LOZJEWOZOKSOKA-UHFFFAOYSA-N |
| :: |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 424728565 | drug_name = MDMEOET | image = MDMEOET.svg | image_class = skin-invert-image | width = 250px | caption =
| pronounce = | tradename = | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = | licence_US = | pregnancy_AU = | pregnancy_category = | dependency_liability = | addiction_liability = | routes_of_administration = Oral | class = | ATC_prefix = None | ATC_suffix =
| legal_status =
| bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = | duration_of_action = Unknown | excretion =
| CAS_number_Ref = | CAS_number = 74698-44-5 | CAS_supplemental = | PubChem = 44719584 | PubChemSubstance = | IUPHAR_ligand = | DrugBank = | ChemSpiderID_Ref = | ChemSpiderID = 21106334 | UNII = YPA4B5U3U8 | KEGG = | ChEBI = | ChEMBL = | NIAID_ChemDB = | PDB_ligand = | synonyms = 3,4-Methylenedioxy-N-methoxyethylamphetamine; MDMEOET; MDMEOETA
| IUPAC_name = 1-(2H-1,3-benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine | C=13 | H=19 | N=1 | O=3 | SMILES = CC(Cc1ccc2c(c1)OCO2)NCCOC | StdInChI_Ref = | StdInChI = 1S/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 | StdInChIKey_Ref = | StdInChIKey = LOZJEWOZOKSOKA-UHFFFAOYSA-N
MDMEOET, also known as 3,4-methylenedioxy-N-methoxyethylamphetamine, is a lesser-known drug and a substituted amphetamine. It is also the N-methoxyethyl analogue of MDA. MDMEOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
References
References
- {{CitePiHKAL
- "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design.
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::